HighTower Advisors LLC Acquires 5,447 Shares of Intuitive Surgical, Inc. $ISRG

HighTower Advisors LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% during the 4th quarter, Holdings Channel reports. The firm owned 200,450 shares of the medical equipment provider’s stock after acquiring an additional 5,447 shares during the period. HighTower Advisors LLC’s holdings in Intuitive Surgical were worth $113,527,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the business. Brighton Jones LLC raised its position in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the period. Sivia Capital Partners LLC grew its position in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the period. Schnieders Capital Management LLC. grew its position in shares of Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after acquiring an additional 268 shares during the period. Osterweis Capital Management Inc. purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $200,000. Finally, Main Street Financial Solutions LLC raised its holdings in shares of Intuitive Surgical by 92.4% in the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after purchasing an additional 1,407 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.4%

Intuitive Surgical stock opened at $441.58 on Wednesday. The firm has a 50 day simple moving average of $461.52 and a 200 day simple moving average of $512.36. Intuitive Surgical, Inc. has a 1-year low of $417.74 and a 1-year high of $603.88. The firm has a market capitalization of $156.39 billion, a price-to-earnings ratio of 53.52, a P/E/G ratio of 3.51 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same period last year, the company earned $1.81 earnings per share. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 105 shares of the stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The SEC filing for this sale provides additional information. Insiders have sold a total of 5,647 shares of company stock worth $2,760,359 in the last three months. 0.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms recently commented on ISRG. Robert W. Baird upped their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Sanford C. Bernstein raised their target price on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. TD Cowen dropped their price target on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Leerink Partners cut their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. Finally, BTIG Research reissued a “buy” rating and issued a $574.00 price objective on shares of Intuitive Surgical in a report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $579.33.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.